Loading...
MTAAFF
Market cap187mUSD
Dec 23, Last price  
7.44EUR
1D
0.81%
1Q
-12.47%
Jan 2017
-19.72%
IPO
-20.94%
Name

Fine Foods & Pharmaceuticals NTM SpA

Chart & Performance

D1W1MN
MTAA:FF chart
P/E
P/S
0.72
EPS
Div Yield, %
1.36%
Shrs. gr., 5y
19.79%
Rev. gr., 5y
12.56%
Revenues
252m
+21.73%
00139,386,516159,658,112173,034,559194,423,560206,852,576251,811,791
Net income
-4m
L-62.93%
-196,837-187,4128,686,2866,069,58513,364,228-1,426,752-9,501,144-3,522,098
CFO
19m
+402.61%
54,286-63,508-2,976,81319,205,43330,466,944-5,826,7153,688,37418,538,195
Dividend
Jun 03, 20240.12 EUR/sh
Earnings
Mar 27, 2025

Profile

Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders and granules, capsules, tablets, film-coated tablets, effervescent granules, and hard gelatine capsules. The company also provides nutraceutical products comprising soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatin capsules for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company manufactures and trades in cosmetics products consisting of hair care, skin care, liquid detergents for personal hygiene, skin care emulsions, oral hygiene, deodorants, alcohol-based perfumery, bath and shower gel, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, and liquid soaps; medical surgical aids and medical devices; antiseptics for undamaged skin, hand gel, pre-injection, hydroalcoholic surfaces, and iodine; and orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. The company was founded in 1984 and is headquartered in Verdellino, Italy.
IPO date
Oct 19, 2016
Employees
Domiciled in
IT
Incorporated in
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
251,812
21.73%
206,853
6.39%
194,424
12.36%
Cost of revenue
186,206
177,920
157,266
Unusual Expense (Income)
NOPBT
65,606
28,933
37,157
NOPBT Margin
26.05%
13.99%
19.11%
Operating Taxes
1,667
(4,698)
(3,164)
Tax Rate
2.54%
NOPAT
63,939
33,631
40,321
Net income
(3,522)
-62.93%
(9,501)
565.93%
(1,427)
-110.68%
Dividends
(2,453)
(3,867)
(3,206)
Dividend yield
1.11%
1.89%
0.87%
Proceeds from repurchase of equity
(341)
(7,012)
BB yield
0.15%
1.90%
Debt
Debt current
55,624
40,565
69,006
Long-term debt
12,154
82,670
45,671
Deferred revenue
(241)
(1,081)
Other long-term liabilities
2,204
2,701
4,127
Net debt
48,624
46,490
19,586
Cash flow
Cash from operating activities
18,538
3,688
(5,827)
CAPEX
(18,126)
(15,984)
(15,920)
Cash from investing activities
45,888
(15,315)
(36,348)
Cash from financing activities
(55,658)
4,740
55,951
FCF
60,560
24,471
(10,534)
Balance
Cash
19,155
76,745
95,090
Long term investments
Excess cash
6,564
66,402
85,369
Stockholders' equity
31,772
30,485
74,987
Invested Capital
188,980
224,546
185,733
ROIC
30.92%
16.39%
25.80%
ROCE
33.51%
11.33%
14.19%
EV
Common stock shares outstanding
25,158
24,538
23,941
Price
8.77
5.16%
8.34
-45.84%
15.40
46.67%
Market cap
220,634
7.81%
204,646
-44.49%
368,687
43.55%
EV
269,258
251,136
388,274
EBITDA
82,409
44,405
50,559
EV/EBITDA
3.27
5.66
7.68
Interest
4,808
2,083
701
Interest/NOPBT
7.33%
7.20%
1.89%